Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Visa-versa! Breaking Instead of Pushing the Pedals: Eccentric Exercise to Improve Training Performance in Patients With Chronic Lung Disease. A Single-center Randomized Controlled Trial
Eccentric muscle work is defined as lengthening of a muscle while applying force. It was shown that with eccentric work, muscles are able to perform four times as much power compared to usual concentric work, which results in huge training gain with a highly decreased oxygen demand and thus lower cardiovascular load. Pulmonary hypertension (PH) is a chronic condition associated with significant reduced exercise capacity and increased morbidity and mortality, resulting in reduced quality of life. Physical training has been shown to be beneficial in PH, even in severely limited patients. However, due to cardiopulmonary constraints in PH, training intensities may be very low, so that many patients are physically almost unable to perform exercise on a high enough level to maintain muscle mass. A low body muscle not only feeds the vicious cycle of decreasing exercise capacity, but also has many deleterious metabolic and immunological consequences which further increase disability and decrease quality of life in PH. Thus, eccentric training, which allows to gain muscle mass with a low stress to the cardiopulmonary unit may to be highly beneficial for patients with PH and allied cardiopulmonary disease, such as chronic obstructive pulmonary disease (COPD) and heart failure. Therefore, the aim of the study is to compare differences in oxygen uptake (peak VO2 [l/min]) and other physiological measures during similar cardiopulmonary exercise test protocols of eccentric- vs. concentric cycling in PH- patients and comparators with or without other cardiopulmonary diseases.
Status | Recruiting |
Enrollment | 16 |
Est. completion date | December 31, 2024 |
Est. primary completion date | July 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - In a stable condition on the same disease specific medication >4 weeks. - Signed informed consent. - Patients with chronic obstructive pulmonary (COPD) with a FEV1/FVC-ratio > 0.7 Exclusion Criteria: - Severe daytime hypoxemia (pO2 =7.3 kPa or <55 mmHg). - Other clinically significant concomitant disease states (e.g., renal, hepatic dysfunction, etc.). - Inability to follow the procedures of the study, e.g. due to language problems, psychological disorder, dementia or confusional state of the subject, neurological or orthopedic problems with inability to ride a bicycle. - Woman with known pregnancy (Women with known pregnancy will not be allowed into the study. It will however not be searched for early unknown pregnancy in woman of child-bearing potential, as cycling is not contraindicated in early unknown pregnancy stage and we thus do not plan routine pregnancy tests before study entrance in women of childbearing potential). - Enrolment into another clinical trial with active treatment. |
Country | Name | City | State |
---|---|---|---|
Switzerland | Respiratory Clinic, University Hospital of Zurich | Zurich |
Lead Sponsor | Collaborator |
---|---|
University of Zurich |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Oxygen uptake (peak VO2 [l/min]) | Difference in oxygen uptake (peak VO2 [l/min]) of eccentric vs. concentric cycling exercise. | 1 Day | |
Secondary | Respiratory exchange ratio (RER) | Volume carbon dioxide devided by the volume of oxygen( VCO2/VO2) | 1 day | |
Secondary | Breathing equivalent for carbon dioxide | Minute ventilation divided by volume carbon dioxide (VE/VCO2) | 1 day | |
Secondary | Pulmonary end tidal carbon dioxide (PET CO2) | The level of carbon dioxide that is released at the end of an exhaled breath | 1 day | |
Secondary | Arterial oxygen saturation (SpO2) | Noninvasively measured oxygenation of the hemoglobin by pulse oximetry (Light Sensors) | 1 day | |
Secondary | Borg Scale for dyspnea | Patient reported level of dyspnea on the Borg Scale from minimum 0 to maximum 10 while 10 is the worst dyspnea and 0 is no dyspnea. | 1 day | |
Secondary | Borg Scale for leg fatigue | Patient reported level of leg fatigue on the Borg Scale from minimum 0 to maximum 10 while 10 is the worst leg fatigue and 0 i no leg fatigue. | 1 day | |
Secondary | Cardiac output | How many liters blood is the heart able to move in one minute. Assessed by echocardiography. | 1 day | |
Secondary | Pulmonary Artery Pressure | Right ventricle pressure divided by the right atrium pressure gradient (RV/RA pressure gradient) to assess the systolic pulmonary artery pressure by echocardiography | 1 day | |
Secondary | Blood pressure | Systolic and diastolic blood pressure assessed by arm cuff measurement | 1 day | |
Secondary | Brain tissue oxygenation | Oxygenation of the brain tissue assessed by light sensors on the forehead | 1 day | |
Secondary | Muscle tissue oxygenation | Oxygenation of the muscle tissue assessed by light sensors on the quadriceps muscle | 1 day | |
Secondary | Arterial blood gases: PH | Arterial blood gases: PH, assessed by arterial blood sample | 1 day | |
Secondary | Arterial blood gases: Partialpressure for oxygen (PaO2) | Arterial blood gases: Partialpressure for oxygen (PaO2), assessed by arterial blood sample | 1 day | |
Secondary | Arterial blood gases: Bicarbonate (HCO3) | Arterial blood gases: Bicarbonate (HCO3), assessed by arterial blood sample | 1 day | |
Secondary | Arterial blood gases: lactate | Arterial blood gases: lactate, assessed by arterial blood sample | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|